α -Lipoic acid inhibits helicobacter pylori -induced oncogene expression and hyperproliferation by suppressing the activation of NADPH oxidase in gastric epithelial cells

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Byun, Eunyoung ^a   Lim, Joo Weon ^a   Kim, Jung Mogg ^b   Kim, Hyeyoung ^a  

^a Yonsei University   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DIPHENYLIODONIUM SALT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIOCTIC ACID; THYMIDINE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL COUNT; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION; GENE INDUCTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; ONCOGENE; ONCOGENE C MYC; STOMACH EPITHELIUM; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; REAL TIME POLYMERASE CHAIN REACTION; STOMACH; STOMACH MUCOSA; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EPITHELIAL CELLS; GASTRIC MUCOSA; HELICOBACTER PYLORI; HUMANS; NADPH OXIDASES; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH; THIOCTIC ACID;

EID: 84907236500     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/380830     Document Type: Article

References (58)

1. Forman D., Newel D. G., Fullerton F., Yarnell J. W. G., Stacey A. R., Wald N., Sitas F., Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. British Medical Journal 1991 302 6788 1302 1305 10.1136/bmj.302.6788.1302 2-s2.0-0025871037
2. Parsonnet J., Friedman G. D., Vandersteen D. P., Chang Y., Vogelman J. H., Orentreich N., Sibley R. K., Helicobacter pylori infection and the risk of gastric carcinoma. The New England Journal of Medicine 1991 325 16 1127 1131 10.1056/NEJM199110173251603 2-s2.0-0025945933
3. Nomura A., Stemmermann G. N., Chyou P., Kato I., Perez-Perez G. I., Blaser M. J., Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. The New England Journal of Medicine 1991 325 16 1132 1136 10.1056/NEJM199110173251604 2-s2.0-0026050956
4. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N., Schlemper R. J., Helicobacter pylori infection and the development of gastric cancer. The New England Journal of Medicine 2001 345 11 784 789 10.1056/NEJMoa001999 2-s2.0-0035856021
5. Jones N. L., Shannon P. T., Cutz E., Yeger H., Sherman P. M., Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. The American Journal of Pathology 1997 151 6 1695 1703 2-s2.0-0030668211
6. Nagy T. A., Wroblewski L. E., Wang D., Piazuelo M. B., Delgado A., Romero-Gallo J., Noto J., Israel D. A., Ogden S. R., Correa P., Cover T. L., Peek R. M. Jr., β -catenin and p120 mediate PPAR δ -dependent proliferation induced by helicobacter pylori in human and rodent epithelia. Gastroenterology 2011 141 2 553 564 10.1053/j.gastro.2011.05.004 2-s2.0-80051506744
7. Gnad T., Feoktistova M., Leverkus M., Lendeckel U., Naumann M., Helicobacter pylori -induced activation of β -catenin involves low density lipoprotein receptor-related protein 6 and Dishevelled. Molecular Cancer 2010 9, article 31 10.1186/1476-4598-9-31 2-s2.0-77349095481
8. Clevers H., Nusse R., Wnt/ β -catenin signaling and disease. Cell 2012 149 6 1192 1205 10.1016/j.cell.2012.05.012 2-s2.0-84861986053
9. Logan C. Y., Nusse R., The Wnt signaling pathway in development and disease. Annual Review of Cell and Developmental Biology 2004 20 1 781 810 10.1146/annurev.cellbio.20.010403.113126 2-s2.0-8444251784
10. Barker N., Morin P. J., Clevers H., The Yin-Yang of TCF/ β -catenin signaling. Advances in Cancer Research 2000 77 1 24 2-s2.0-0033992481
11. Behrens J., Jerchow B., Würtele M., Grimm J., Asbrand C., Wirtz R., Kühl M., Wedlich D., Birchmeier W., Functional interaction of an axin homolog, conductin, with β -catenin, APC, and GSK3 β Science 1998 280 5363 596 599 10.1126/science.280.5363.596 2-s2.0-0032562603
12. MacLeod R. J., MDR-1, Bcl-xL, H. pylori, and Wnt/ β -catenin signalling in the adult stomach: how much is too much? Laboratory Investigation 2012 92 12 1670 1673 10.1038/labinvest.2012.151 2-s2.0-84870432751
13. Himaya S. W. A., Dewapriya P., Kim S., EGFR tyrosine kinase inhibitory peptide attenuates Helicobacter pylori-mediated hyper-proliferation in AGS enteric epithelial cells. Toxicology and Applied Pharmacology 2013 269 3 205 214 10.1016/j.taap.2013.03.020 2-s2.0-84876971455
14. Shih I. M., Yu J., He T. C., Vogelstein B., Kinzler K. W., The β -catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. Cancer Research 2000 60 6 1671 1676 2-s2.0-0034653689
15. Dang C. V., c-Myc target genes involved in cell growth, apoptosis, and metabolism. Molecular and Cellular Biology 1999 19 1 1 11 2-s2.0-0032905924
16. Seo J. H., Lim J. W., Kim H., Kim K. H., Helicobacter pylori in a Korean isolate activates mitogen-activated protein kinases, AP-1, and NF- B and induces chemokine expression in gastric epithelial AGS cells. Laboratory Investigation 2004 84 1 49 62 10.1038/sj.labinvest.3700010 2-s2.0-1542466656
17. Keenan J. I., Peterson R. A. II, Hampton M. B., NADPH oxidase involvement in the pathology of Helicobacter pylori infection. Free Radical Biology and Medicine 2005 38 9 1188 1196 10.1016/j.freeradbiomed.2004.12.025 2-s2.0-15944367779
18. Tominaga K., Kawahara T., Sano T., Toida K., Kuwano Y., Sasaki H., Kawai T., Teshima-Kondo S., Rokutan K., Evidence for cancer-associated expression of NADPH oxidase 1 (Nox1)-based oxidase system in the human stomach. Free Radical Biology and Medicine 2007 43 12 1627 1638 10.1016/j.freeradbiomed.2007.08.029 2-s2.0-36249019169
19. Cha B., Lim J. W., Kim K. H., Kim H., 15-deoxy-Δ12,14-prostaglandin j2 suppresses rantes expression by inhibiting nadph oxidase activation in helicobacter pylori-infected gastric epithelial cells. Journal of Physiology and Pharmacology 2011 62 2 167 174 2-s2.0-79959338435
20. Babior B. M., Lambeth J. D., Nauseef W., The neutrophil NADPH oxidase. Archives of Biochemistry and Biophysics 2002 397 2 342 344 10.1006/abbi.2001.2642 2-s2.0-0037082101
21. Nollet F., Berx G., Molemans F., Van Roy F., Genomic organization of the human β -catenin gene (CTNNB1). Genomics 1996 32 3 413 424 10.1006/geno.1996.0136 2-s2.0-0029991079
22. Götschel F., Kern C., Lang S., Sparna T., Markmann C., Schwager J., McNelly S., von Weizsäcker F., Laufer S., Hecht A., Merfort I., Inhibition of GSK3 differentially modulates NF- B, CREB, AP-1 and β -catenin signaling in hepatocytes, but fails to promote TNF- α -induced apoptosis. Experimental Cell Research 2008 314 6 1351 1366 10.1016/j.yexcr.2007.12.015 2-s2.0-40049099291
23. Reed L. J., A trail of research from lipoic acid to alpha- keto acid dehydrogenase complexes. The Journal of Biological Chemistry 2001 276 42 38329 38336 10.1074/jbc.R100026200 2-s2.0-0035914303
24. Bast A., Haenen G. R. M. M., Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation. Biochimica et Biophysica Acta 1988 963 3 558 561 10.1016/0005-2760(88)90326-8 2-s2.0-0024208540
25. Packer L., α -Lipoic acid: a metabolic antioxidant which regulates NF- B signal transduction and protects against oxidative injury. Drug Metabolism Reviews 1998 30 2 245 275 10.3109/03602539808996311 2-s2.0-0031803334
26. Vig-Varga E., Benson E. A., Limbil T. L., Allison B. M., Goebl M. G., Harrington M. A., Alpha-lipoic acid modulates ovarian surface epithelial cell growth. Gynecologic Oncology 2006 103 1 45 52 10.1016/j.ygyno.2006.01.060 2-s2.0-33748529374
27. Wenzel U., Nickel A., Daniel H., α -lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2-.-generation. Apoptosis 2005 10 2 359 368 10.1007/s10495-005-0810-x 2-s2.0-18044392727
28. Lee S. E., Lim J. W., Kim J. M., Kim H., Anti-inflammatory mechanism of polyunsaturated fatty acids in Helicobacter pylori -infected gastric epithelial cells. Mediators of Inflammation 2014 2014 12 128919 10.1155/2014/128919
29. Lim J. W., Kim H., Kim K. H., Nuclear factor- B regulates cyclooxyoenase-2 expression and cell proliferation in human gastric cancer cells. Laboratory Investigation 2001 81 3 349 360 10.1038/labinvest.3780243 2-s2.0-0035086794
30. Goraca A., Huk-Kolega H., Piechota A., Kleniewska P., Ciejka E., Skibska B., Lipoic acid-biological activity and therapeutic potential. Pharmacological Reports 2011 63 4 849 858 10.1016/S1734-1140(11)70600-4 2-s2.0-80053351784
31. Jang S. H., Lim J. W., Morio T., Kim H., Lycopene inhibits Helicobacter pylori-induced ATM/ATR-dependent DNA damage response in gastric epithelial AGS cells. Free Radical Biology and Medicine 2012 52 3 607 615 10.1016/j.freeradbiomed.2011.11.010 2-s2.0-84856244379
32. Yu J. H., Kim K. H., Kim D. G., Kim H., Diphenyleneiodonium suppresses apoptosis in cerulein-stimulated pancreatic acinar cells. International Journal of Biochemistry and Cell Biology 2007 39 11 2063 2075 10.1016/j.biocel.2007.05.021 2-s2.0-34548501984
33. Mulholland D. J., Cheng H., Reid K., Rennie P. S., Nelson C. C., The androgen receptor can promote β -catenin nuclear translocation independently of adenomatous polyposis coli. The Journal of Biological Chemistry 2002 277 20 17933 17943 10.1074/jbc.M200135200 2-s2.0-0037124062
34. Bhatti F., Mankhey R. W., Asico L., Quinn M. T., Welch W. J., Maric C., Mechanisms of antioxidant and pro-oxidant effects of α -lipoic acid in the diabetic and nondiabetic kidney. Kidney International 2005 67 4 1371 1380 10.1111/j.1523-1755.2005.00214.x 2-s2.0-16244413938
35. Bilska A., Włodek L., Lipoic acid-the drug of the future? Pharmacological Reports 2005 57 5 570 577 2-s2.0-33644664987
36. Arambašić J., Mihailović M., Uskoković A., Dinić S., Grdović N., Marković J., Poznanović G., Bajec D., Vidaković M., Alpha-lipoic acid upregulates antioxidant enzyme gene expression and enzymatic activity in diabetic rat kidneys through an O-GlcNAc-dependent mechanism. European Journal of Nutrition 2013 52 5 1461 1473 10.1007/s00394-012-0452-z 2-s2.0-84875441398
37. Wang L., Wu C. G., Fang C. Q., Gao J., Liu Y., Chen Y., Xu Z., The protective effect of α -lipoic acid on mitochondria in the kidney of diabetic rats. International Journal of Clinical and Experimental Medicine 2013 6 2 90 97 2-s2.0-84873177708
38. He L., Liu B., Dai Z., Zhang H., Zhang Y., Luo X., Ma Q., Peng J., Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation. European Journal of Pharmacology 2012 678 1-3 32 38 10.1016/j.ejphar.2011.12.042 2-s2.0-84862781173
39. Deng C., Sun Z., Tong G., Yi W., Ma L., Zhao B., Cheng L., Zhang J., Cao F., Yi D., α -Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfusion injury through activation of PI3K/ Akt /Nrf2 pathway. PLoS ONE 2013 8 3 e58371 10.1371/journal.pone.0058371 2-s2.0-84874678796
40. Kaya M., Yildirim C. H., Kosemehmetoglu K., Huseyinoglu U., Erdogan H., Akbasak A., Tasdemiroglu E., Alpha-lipoic acid reduces peridural fibrosis after laminectomy of lumbar vertebrae in rabbits. Acta Neurochirurgica 2012 154 7 1241 1245 10.1007/s00701-012-1382-5 2-s2.0-84865713640
41. Lee J. E., Yi C., Jeon B. T., Shin H. J., Kim S. K., Jung T. S., Choi J. Y., Roh G. S., Alpha-lipoic acid attenuates cardiac fibrosis in Otsuka Long-Evans Tokushima Fatty rats. Cardiovascular Diabetology 2012 11, article 111 10.1186/1475-2840-11-111 2-s2.0-84866287052
42. Farr S. A., Price T. O., Banks W. A., Ercal N., Morley J. E., Effect of alpha-lipoic acid on memory, oxidation, and lifespan in SAMP8 mice. Journal of Alzheimer's Disease 2012 32 2 447 455 10.3233/JAD-2012-120130 2-s2.0-84867488056
43. Liu B., Ma X., Guo D., Guo Y., Chen N., Bi H., Neuroprotective effect of α -lipoic acid on hydrostatic pressure-induced damage of retinal ganglion cells in vitro. Neuroscience Letters 2012 526 1 24 28 10.1016/j.neulet.2012.08.016 2-s2.0-84865655016
44. Yoo T., Lee J., Chun H., Chi S., α -Lipoic acid prevents p53 degradation in colon cancer cells by blocking NF- B induction of RPS6KA4. Anti-Cancer Drugs 2013 24 6 555 565 10.1097/CAD.0b013e32836181eb 2-s2.0-84878951705
45. Michikoshi H., Nakamura T., Sakai K., Suzuki Y., Adachi E., Matsugo S., Matsumoto K., α -Lipoic acid-induced inhibition of proliferation and met phosphorylation in human non-small cell lung cancer cells. Cancer Letters 2013 335 2 472 478 10.1016/j.canlet.2013.03.008 2-s2.0-84878263590
46. Yamasaki M., Iwase M., Kawano K., α -Lipoic acid suppresses migration and invasion via downregulation of cell surface β 1-integrin expression in bladder cancer cells. Journal of Clinical Biochemistry and Nutrition 2014 54 1 18 25
47. Bandapalli O. R., Dihlmann S., Helwa R., Macher-Goeppinger S., Weitz J., Schirmacher P., Brand K., Transcriptional activation of the β -catenin gene at the invasion front of colorectal liver metastases. Journal of Pathology 2009 218 3 370 379 10.1002/path.2539 2-s2.0-67650077103
48. Ki M. R., Hwang M., Kim A. Y., Role of vacuolating cytotoxin VacA and cytotoxin -associated antigen CagA of Helicobacter pylori in the progression of gastric cancer. Molecular and Cellular Biochemistry 2014
49. Aziz F., Chen X., Yang X., Yan Q., Prevalence and correlation with clinical diseases of Helicobacter pylori cagA and vacA genotype among gastric patients from Northeast China. BioMed Research International 2014 2014 7 142980 10.1155/2014/142980
50. Akopyants N. S., Clifton S. W., Kersulyte D., Crabtree J. E., Youree B. E., Reece C. A., Bukanov N. O., Drazek E. S., Roe B. A., Berg D. E., Analyses of the cag pathogenicity island of Helicobacter pylori. Molecular Microbiology 1998 28 1 37 53 10.1046/j.1365-2958.1998.00770.x 2-s2.0-14444281381
51. Keates S., Keates A. C., Warny M., Peek R. M. Jr., Murray P. G., Kelly C. P., Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag- Helicobacter pylori. Journal of Immunology 1999 163 10 5552 5559 2-s2.0-0033571334
52. Kuipers E. J., Perez-Perez G. I., Meuwissen S. G. M., Blaser M. J., Helicobacter pylori and atrophic gastritis: importance of the cagA status. Journal of the National Cancer Institute 1995 87 23 1777 1780 10.1093/jnci/87.23.1777 2-s2.0-0028789305
53. Blaser M. J., Perez-Perez G. I., Kleanthous H., Cover T. L., Peek R. M., Chyou P. H., Stemmermann G. N., Nomura A., Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Research 1995 55 10 2111 2115 2-s2.0-0029043658
54. Yang G., Deng C., Xiong Y., Gong L., Wang B., Luo J., Expression of nuclear factor-kappa B and target genes in gastric precancerous lesions and adenocarcinoma: association with Helicobacter pylori cagA (+) infection. World Journal of Gastroenterology 2004 10 4 491 496 2-s2.0-1542284714
55. Higashi H., Tsutsumi R., Muto S., Sugiyama T., Azuma T., Asaka M., Hatakeyama M., SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002 295 5555 683 686 10.1126/science.1067147 2-s2.0-0037169076
56. 2+influx, mitochondrial reactive oxygen intermediates, and NF- B activation. Infection and Immunity 2007 75 7 3373 3381 10.1128/IAI.01940-06 2-s2.0-34447268735
57. Labigne A., de Reuse H., Determinants of Helicobacter pylori pathogenicity. Infectious Agents and Disease 1996 5 4 191 202 2-s2.0-0029838654
58. Mobley H. L., Defining Helicobacter pylori as a pathogen: strain heterogeneity and virulence. The American Journal of Medicine 1996 100 5A 2S 9S 2-s2.0-0029938950